[HTML][HTML] Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity

L Cui, F Zhou, C Chen, CC Wang - Journal of Ovarian Research, 2019 - Springer
Objectives The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …

Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity.

L Cui, F Zhou, C Chen, CC Wang - Journal of Ovarian Research, 2019 - go.gale.com
Objectives The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …

[HTML][HTML] Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity

L Cui, F Zhou, C Chen, CC Wang - Journal of Ovarian Research, 2019 - ncbi.nlm.nih.gov
Objectives The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …

[PDF][PDF] Overexpression of CCDC69 activates p14 ARF/MDM2/p53 pathway and confers cisplatin sensitivity

L Cui, F Zhou, C Chen, CC Wang - 2019 - scholar.archive.org
Objectives: The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …

[HTML][HTML] Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity

L Cui, F Zhou, C Chen… - Journal of …, 2019 - ovarianresearch.biomedcentral.com
The aim of the study is to explore the relationship between CCDC69 expression and
resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism. One …

Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity.

L Cui, F Zhou, C Chen, CC Wang - Journal of Ovarian Research, 2019 - europepmc.org
Objectives The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …

Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity

L Cui, F Zhou, C Chen… - Journal of ovarian …, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …

Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity

C Long, F Zhou, C Chen… - Journal of Ovarian …, 2019 - search.proquest.com
Objectives The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …

[PDF][PDF] Overexpression of CCDC69 activates p14 ARF/MDM2/p53 pathway and confers cisplatin sensitivity

L Cui, F Zhou, C Chen, CC Wang - 2019 - academia.edu
Objectives: The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …

Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity.

L Cui, CC Wang, F Zhou… - Journal of Ovarian …, 2019 - search.ebscohost.com
Objectives: The aim of the study is to explore the relationship between CCDC69 expression
and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism …